共 50 条
- [5] Enhancing the antitumor response of CD8+ T cells by 4-1BB (CD137) co-stimulation with distinct inactivation of the type 2 adenosine receptors JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
- [8] Therapeutic potential of 4-1BB (CD137) as a regulator for effector CD8+ T cells JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (04): : 441 - 449
- [9] 4-1BB Signaling Breaks the Tolerance of Maternal CD8+ T Cells That Are Reactive with Alloantigens PLOS ONE, 2012, 7 (09):